Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Nasal Steroids for Residual Smell Loss After Sinus Surgery
NCT01814618Phase 2Withdrawn
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Mar 2013
- Primary completion
- Nov 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of budesonide in Olfactory disorder, chronic rhinosinusitis (CRS), sponsored by University of North Carolina at Chapel Hill. Planned start Mar 2013; status: withdrawn.
02
Drugs
budesonide
03
Conditions
Olfactory disorderchronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT01814618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01814618.